Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension, Primary, 2”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Not applicableStudy completedNCT05767918
What this trial is testing

StratosPHere (Non-interventional Study)

Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary Arterial HypertensionPulmonary Hypertension+1 more
Papworth Hospital NHS Foundation Trust 65
Testing effectiveness (Phase 2)Study completedNCT06664801
What this trial is testing

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 164
Testing effectiveness (Phase 2)Looking for participantsNCT06846554
What this trial is testing

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Apollo Therapeutics Ltd 48
Large-scale testing (Phase 3)Study completedNCT00810693
What this trial is testing

Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Hypertension
Bayer 445
Testing effectiveness (Phase 2)Study completedNCT02279160
What this trial is testing

Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 61
Testing effectiveness (Phase 2)Study completedNCT03638908
What this trial is testing

Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial

Who this might be right for
Pulmonary Arterial Hypertension
University of Texas Southwestern Medical Center 8
Testing effectiveness (Phase 2)Study completedNCT02234141
What this trial is testing

Selonsertib in Adults With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Gilead Sciences 151
Testing effectiveness (Phase 2)Active Not RecruitingNCT02682511
What this trial is testing

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

Who this might be right for
Scleroderma, DiffuseScleroderma, SystemicScleroderma, Limited+5 more
Cumberland Pharmaceuticals 34
Testing effectiveness (Phase 2)Ended earlyNCT02507011
What this trial is testing

Beta-blockers in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
University of Minnesota 2
Testing effectiveness (Phase 2)Study completedNCT00424021
What this trial is testing

Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Gilead Sciences 54
Testing effectiveness (Phase 2)Study completedNCT01179334
What this trial is testing

Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters.

Who this might be right for
Pulmonary Hypertension
Bayer 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT03492177
What this trial is testing

A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 63
Testing effectiveness (Phase 2)Looking for participantsNCT05587712
What this trial is testing

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 42
Testing effectiveness (Phase 2)Ended earlyNCT01725256
What this trial is testing

Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 29
Large-scale testing (Phase 3)Study completedNCT00091598
What this trial is testing

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Hypertension
Gilead Sciences 372
Large-scale testing (Phase 3)Ended earlyNCT02725372
What this trial is testing

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH

Who this might be right for
Pulmonary Arterial Hypertension
Bellerophon Pulse Technologies 207
Testing effectiveness (Phase 2)Ended earlyNCT03449524
What this trial is testing

PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
PAH
Complexa, Inc. 69
Testing effectiveness (Phase 2)Ended earlyNCT00832507
What this trial is testing

Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Gilead Sciences 162
Large-scale testing (Phase 3)Study completedNCT04732221
What this trial is testing

The Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)

Who this might be right for
Pulmonary Arterial HypertensionHypertension, Pulmonary
Merck Sharp & Dohme LLC 168
Testing effectiveness (Phase 2)Study completedNCT05224531
What this trial is testing

Effect of CS1 in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Cereno Scientific AB 25
Load More Results